Home / Drug shortages / Midazolam Hydrochloride Injection

Midazolam Hydrochloride Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Midazolam Hydrochloride Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on 04/02/2020.

Shortage Details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0641-6060-10
Dosage Form
Injection
Presentation
Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6060-10)
Initial Posting
04/02/2020
Revised Date

FDA data resources